Evidence map›Paper›PMID 32082082›Full record

ReviewJournal of inflammation (London, England)2020

Real-state of autophagy signaling pathway in neurodegenerative disease; focus on multiple sclerosis.

Mehdi Hassanpour, Fateme Hajihassani, Amirataollah Hiradfar, Nasser Aghamohammadzadeh, Reza Rahbarghazi, Nasser Safaie, Mohammad Nouri, Yunes Panahi

Open access · goldAbstract readReview
In one paragraph

Review in Journal of inflammation (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. RNA Sequencing of CD4Journal of molecular neuroscience : MN · 2021
    Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Autophagy in Multiple Sclerosis: Two Sides of the Same Coin.Frontiers in cellular neuroscience · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Mehdi Hassanpour1Department of Clinical Biochemistry and Laboratory Medicine, Tabriz University of Medical Sciences, 5166614756, Imam Reza St., Golgasht St, Tabriz, Iran.ORCID 0000-0003-4836-9213
Fateme Hajihassani4Department of Health Management, School of Management and Medical informatics, Tabriz University of Medical Sciences, Tabriz, Iran.
Amirataollah Hiradfar5Pediatric Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Nasser Aghamohammadzadeh6Endocrine Research Center, Tabriz University of Medical Science, Tabriz, Iran.
Reza Rahbarghazi7Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Nasser Safaie9Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Mohammad Nouri1Department of Clinical Biochemistry and Laboratory Medicine, Tabriz University of Medical Sciences, 5166614756, Imam Reza St., Golgasht St, Tabriz, Iran.
Yunes Panahi3Clinical Pharmacy Department, Faculty of Pharmacy, Baqiyatallah University of Medical Sciences, Tehran, 1435916471 Iran.
Tabriz University of Medical Sciences · IRBaqiyatallah University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The occurrence of neurodegenerative disease is increasingly raised. From physiopathological aspect, the emergence of auto-reactive antibodies against the nervous system antigens contributes to de-myelination in Multiple sclerosis (MS). These features cause the nervous system dysfunction. The follow-up of molecular alterations could give us a real-state vision about intracellular status during pathological circumstances. In this review, we focus on the autophagic response during MS progression and further understand the relationship between autophagy and MS and its modulatory effect on the MS evolution. The authors reviewed studies published on the autophagy status in neurodegenerative disease and on the autophagy modulation in MS prognosis, diagnosis, and possible therapies. The inevitable role of autophagy was shown in the early-stage progression of MS. Due to critical role of autophagy in different stage of cell activity in nervous system, the distinct role of autophagy should not be neglected in the development, pathogenesis, and treatment of MS.

Indexed as

AutophagyMultiple sclerosisNeurodegenerative disease

Identifiers

PMID32082082
PMCPMC7014934
OpenAlexW3008054852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.